Curcumin loaded poly (amidoamine) dendrimer-plamitic acid core-shell nanoparticles as anti-stress therapeutics. (3rd March 2020)

• Record Type: Journal Article
• Authors: Tripathi, Pushpendra Kumar; Gupta, Shraddha; Rai, Suruchi; Shrivatava, Ankur; Tripathi, Shalini; Singh, Sima; Khopade, Ajay J.; Kesharwani, Prashant
• Is Part Of: Drug development and industrial pharmacy. Volume 46:Number 3(2020)
• Page Start: 412
• Page End: 426
• Publication Date: 2020-03-03
• Subjects: Curcumin -- palmitic acid nanoparticles -- PAMAM dendrimer -- drug delivery -- antistress agent; Pharmaceutical chemistry -- Periodicals; Pharmaceutical industry -- Periodicals; Drug Industry -- Periodicals; Technology, Pharmaceutical -- Periodicals; 615.05
• DOI: 10.1080/03639045.2020.1724132
• Languages: English
• ISSNs: 0363-9045

Abstract

Abstract: Despite poor bioavailability of the drug and in vivo stability, curcumin has been reported for many pharmacological activities. Considering the potential of dendrimers as a drug delivery system, current research work is focused on the formulation and characterization of G4 PAMAM dendrimer-Palmitic acid core-shell nanoparticle-containing curcumin as antistress therapeutics to maximize the bioavailability of curcumin. Various formulations were prepared using different concentrations of palmitic acid and an optimized ratio of dendrimer and curcumin. All formulations were investigated for evaluation of physicochemical parameters, encapsulation efficiency, and in vitro release. Particle size, PDI, zeta-potential, and encapsulation efficiency of final formulation was found to be 257.9 ± 0.365 nm, 0.10 ± 0.004, 3.59 ± 0.167 mV, and 80.87%, respectively. In vitro release studies have shown that 53.62 ± 2.431% of the drug was released after 24 h. In vivo studies pharmacokinetic parameters, drug distribution, pharmacological, and toxicological were also estimated using swiss albino mice. The findings have shown the selected formulation is better than plain curcumin formulation.